Indications for Implantable Cardioverter-Defibrillator (ICD) in Patients with Ischemic Heart Disease (IHD) to Prevent Sudden Cardiac Death (SCD)
Patient with ischemic heart disease (IHD) with a meaningful survival >1 year expected
• LVEF < 35%, NYHA class II or Ill HF despite guideline-directed management and therapy
or
• LVEF < 30%, NYHA class I HF despite guideline-directed management and therapy
Do all of the following apply?
• Low left ventricular ejection fraction (LVEF) due to IHD
• > 40 days post-myocardial infarction
• > 90 days postrevascularization
Or ANY of the following:
• Sudden cardiac arrest due to ventricular tachycardia (VT) or ventricular fibrillation (VF)
• Hemodynamically unstable VT
• Stable VT
• Unexplained syncope plus inducible sustained monomorphic VT on EP study
#AICD #defibrillator #indications #cardiology #diagnosis #criteria
